FAAH Gene: How It Shapes Mood, Stress, and Pain

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education

The FAAH gene encodes fatty acid amide hydrolase, an enzyme that breaks down anandamide — one of the body's own cannabinoid-like signaling molecules. Because anandamide influences mood, stress reactivity, and pain sensitivity, variation in FAAH has become one of the more studied genetic links between the endocannabinoid system and how people feel and respond to stress. This article explains what the gene does and what the research actually shows.

What FAAH does in the body

The endocannabinoid system helps regulate mood, appetite, pain, and stress. Anandamide, sometimes called the 'bliss molecule,' activates cannabinoid receptors and is then cleared away by the FAAH enzyme. The more active the enzyme, the faster anandamide is degraded; the less active, the longer it lingers. FAAH therefore acts like a dimmer switch on endocannabinoid signaling, shaping the tone of this system from moment to moment.

This matters because the endocannabinoid system does not work in isolation. It interacts with the brain's stress circuitry, reward pathways, and the systems that process physical pain. By controlling how long anandamide stays active, FAAH sits at a control point that influences all three at once, which is why a single enzyme has drawn so much research attention across mood, anxiety, and pain fields.

The FAAH C385A variant (rs324420)

The most studied FAAH polymorphism is C385A, also written as rs324420. The minor 'A' allele reduces the enzyme's stability, so carriers tend to break down anandamide more slowly and maintain higher endocannabinoid levels. Studies have associated this variant with lower anxiety in some stress contexts, altered fear processing in brain imaging, and differences in pain sensitivity. As with most behavioral genetics, effects are modest and context-dependent, not deterministic.

Mood and stress

Higher anandamide tone linked to the reduced-activity FAAH variant has been associated in research with quicker recovery from stress and reduced anxiety-related brain activity in some studies. This does not mean carriers are immune to anxiety or that non-carriers are destined for it. Environment, sleep, and countless other genes all contribute. Genetics describes a tendency in a pathway, not a fixed outcome.

Pain sensitivity and the COMT connection

Because the endocannabinoid system modulates pain signaling, FAAH variation has been studied in relation to pain thresholds, with the reduced-activity allele linked to higher pain tolerance in some cohorts. Pain perception is polygenic, and another well-known contributor is COMT, which shapes dopamine and stress-hormone breakdown and is repeatedly tied to individual differences in pain and stress responses. Looking at these genes together gives a richer pathway-level picture than any single variant.

What genetic insight can and cannot tell you

Knowing your FAAH status is interesting context, not a diagnosis or a treatment plan. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, offering a pathway-level view of biology such as endocannabinoid signaling, mood, and stress pathways. It does not diagnose or treat anxiety, depression, or chronic pain, and it does not predict how you will respond to any medication. PlexusDx tells you about your biology; it does not tell you what to put in your body.

Frequently Asked Questions

What does the FAAH gene do?

FAAH encodes fatty acid amide hydrolase, the enzyme that breaks down anandamide, an endocannabinoid that influences mood, stress, and pain. More enzyme activity clears anandamide faster; less activity lets it linger, effectively adjusting the tone of endocannabinoid signaling throughout the body.

What is the FAAH C385A (rs324420) variant?

C385A is the most studied FAAH polymorphism. The minor 'A' allele reduces enzyme stability, so carriers tend to keep higher anandamide levels. Research has linked it to lower anxiety in some contexts and altered pain sensitivity, though effects are modest and depend heavily on environment.

Does FAAH affect pain tolerance?

It may contribute. Some studies associate the reduced-activity FAAH allele with higher pain tolerance because the endocannabinoid system modulates pain signaling. Pain is polygenic, though, and other genes such as COMT also shape individual differences, so no single variant tells the whole story.

Can the PlexusDx test diagnose anxiety or chronic pain?

No. The Precision Peptide Genetic Test does not diagnose or treat anxiety, depression, or pain, and it does not predict medication response. It offers pathway-level context about biology like mood and stress signaling. Discuss any mental-health or pain concerns with a qualified provider.

Curious how your genes shape mood, stress, and pain pathways? Explore the Precision Peptide Genetic Test for a pathway-level view of your biology, then bring what you learn to a qualified provider.

This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.